Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Chief Medical Officer · Imunon, Inc. · Common Stock
Grant or award — administrative, little informational value
$1K reported value · 2.1% of prior position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Braun Donald PDirector | Grant or award | A | $9,925 11.7K sh | Nov 10, 2026 traded Nov 6, 2026 | |
| 21 | Dentzer James EDirector | Grant or award | A | $11K 13.2K sh | Nov 10, 2026 traded Nov 6, 2026 | |
| 21 | Pellizzari Christine ADirector | Grant or award | A | $11K 13.2K sh | Nov 10, 2026 traded Nov 6, 2026 | |
| 9 | Fritz Frederick J.Director | Grant or award | A | $11.13 13 sh | Nov 10, 2026 traded Nov 6, 2026 | |
| 9 | Lindborg StacyDirector, President and CEO | Grant or award | A | $3,214 3,804 sh | Nov 10, 2026 traded Nov 6, 2026 | |
| 13 | Tardugno Michael HDirector, Executive Chairman of Board | Grant or award | A | $8,424 9,969 sh | Nov 10, 2026 traded Nov 6, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $1,349
Faller Douglas Vincent filed this Form 4 reporting a grant or award of IMNN on Nov 6, 2026. It became public on Nov 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.